Literature DB >> 19145036

Elevation of plasma granzyme B levels after acute myocardial infarction.

Hideyuki Kondo1, Yukihiro Hojo, Rie Tsuru, Yoshioki Nishimura, Hayato Shimizu, Nozomu Takahashi, Masahiro Hirose, Tomokazu Ikemoto, Ken-Ichi Ohya, Takaaki Katsuki, Takashi Yashiro, Kazuyuki Shimada.   

Abstract

BACKGROUND: Apoptosis is reported to play an important role in left ventricular (LV) remodeling after acute myocardial infarction (AMI). Granzyme B is a member of the serine esterase family, which has an important role in cellular apoptosis and extracellular matrix degradation. METHODS AND
RESULTS: Peripheral blood samples were obtained from 33 patients with a first-onset AMI treated by percutaneous coronary intervention (mean age: 61.4+/-8.7 years old) on days 1, 7 and 14 after onset. Plasma levels of tumor necrosis factor (TNF)-alpha, a soluble form of the Fas ligand (sFasL), and granzyme B were measured. TIMI grade 3 recanalization was accomplished in all patients within 12 h after onset. The LV end-diastolic volume index (LVEDVI) was calculated on day 1 and at 6 months after onset. Plasma levels of TNF-alpha, sFasL and granzyme B increased significantly on days 7 and 14 after onset of AMI. Stepwise multivariate regression analysis showed that the plasma granzyme B level on day 14 is a significant explanatory variable for changes in the LVEDVI.
CONCLUSIONS: Plasma levels of granzyme B increased after AMI, which might be an important factor in the progression of late LV remodeling after AMI.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19145036     DOI: 10.1253/circj.cj-08-0668

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  13 in total

1.  T-cell regulation of fibroblasts and cardiac fibrosis.

Authors:  Amy D Bradshaw; Kristine Y DeLeon-Pennell
Journal:  Matrix Biol       Date:  2020-05-11       Impact factor: 11.583

2.  Gene expression signatures of coronary heart disease.

Authors:  Roby Joehanes; Saixia Ying; Tianxiao Huan; Andrew D Johnson; Nalini Raghavachari; Richard Wang; Poching Liu; Kimberly A Woodhouse; Shurjo K Sen; Kahraman Tanriverdi; Paul Courchesne; Jane E Freedman; Christopher J O'Donnell; Daniel Levy; Peter J Munson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-28       Impact factor: 8.311

3.  Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Authors:  Adrien Costantini; Catherine Julie; Coraline Dumenil; Zofia Hélias-Rodzewicz; Julie Tisserand; Jennifer Dumoulin; Violaine Giraud; Sylvie Labrune; Thierry Chinet; Jean-François Emile; Etienne Giroux Leprieur
Journal:  Oncoimmunology       Date:  2018-04-20       Impact factor: 8.110

4.  Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1.

Authors:  Wendy A Boivin; Marlo Shackleford; Amanda Vanden Hoek; Hongyan Zhao; Tillie L Hackett; Darryl A Knight; David J Granville
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

5.  Perforin and granzyme B have separate and distinct roles during atherosclerotic plaque development in apolipoprotein E knockout mice.

Authors:  Paul R Hiebert; Wendy A Boivin; Hongyan Zhao; Bruce M McManus; David J Granville
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

6.  Granzyme B releases vascular endothelial growth factor from extracellular matrix and induces vascular permeability.

Authors:  Alon Hendel; Ivy Hsu; David J Granville
Journal:  Lab Invest       Date:  2014-05-05       Impact factor: 5.662

7.  Granzyme B deficiency promotes osteoblastic differentiation and calcification of vascular smooth muscle cells in hypoxic pulmonary hypertension.

Authors:  Min Mao; Min Zhang; Anqi Ge; Xin Ge; Rui Gu; Chen Zhang; Yao Fu; Jiayin Gao; Xiaoying Wang; Yang Liu; Daling Zhu
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

8.  Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine.

Authors:  Hala O El-Mesallamy; Nadia M Hamdy; Adel K El-Etriby; Eman F Wasfey
Journal:  Mediators Inflamm       Date:  2013-11-06       Impact factor: 4.711

Review 9.  Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling.

Authors:  Icia Santos-Zas; Jérémie Lemarié; Alain Tedgui; Hafid Ait-Oufella
Journal:  Front Cardiovasc Med       Date:  2019-01-10

Review 10.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.